
ENTOD Pharmaceuticals announces CDSCO approval of 0.05% atropine drops in India
Published on April 23, 2025

According to a press release, Myatro XL is the first 0.05% atropine eye drops for pediatric myopia control. It will be commercially available in India in July 2025.
